IntelGenx Technologies Corp (OTCMKTS:IGXT) Is Today’s Pharma Focus IntelGenx Technologies Inc (OTCMKTS:IGXT) has quickly run up the charts after the company sold its royalty on future sales of Forfivo XL® to SWK Holdings Corporation (OTCMKTS:SWKH) for $6 million (CAD$8 million). Forfivo XL® (Bupropion extended-release)..